Foresees a noticeable increase of customers, volume, and sales in 2024
STOCKHOLM - February 29, 2024 - Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw important pieces fall into place during the fourth quarter, the foremost being our attainment of accreditation as a medical laboratory. This paved the way for making Inify’s diagnostic service fully available to both private and public healthcare providers, resulting in a sales growth of 176% compared to the third quarter. “I dare to claim that our operations are unique – in Sweden, and internationally. Our ambition is to stay at the forefront in terms of